ストックスクリーナーアプリを入手
25.06
2.83%
-0.73
アフターアワーズ：
25.10
0.04
+0.16%
Pfizer Inc (PFE) 最新ニュース
Analysts’ Top Healthcare Picks: Candel Therapeutics (CADL), Pfizer (PFE) - The Globe and Mail
Pfizer's Rich Dividend Story Meets Overpriced Metsera Acquisition/Patent Cliff Risks - Seeking Alpha
Is Pfizer Stock a Buy After This $10 Billion Acquisition? - MSN
Starboard Value Calls It Quits On Its Pfizer Investment - Finimize
Activist Starboard sells Pfizer stake after pushing for changes - Reuters
Starboard Value Takes Significant Stake in BILL, Exits Pfizer - GuruFocus
Starboard's Q3 moves show previously disclosed new stake in BILL, Pfizer exit (BILL:NYSE) - Seeking Alpha
Law360 Pulse Spotlight On Mid-Law Work - Law360
Starboard Value LP dissolves share stake in Pfizer & Fortrea - MarketScreener
Taxation With Representation: Wachtell, Paul Hastings, Sidley - Law360
Metsera acquisition 'could be a key tailwind' for Pfizer - The Business Journals
Why Pfizer (PFE) Shares Are Sliding Today - Finviz
Pfizer 3Q Results - Contract Pharma
Novo Chairman Blames Board Dropout on Former Employer Pfizer - Yahoo Finance
Novo’s new chairman urged to curb risk after Metsera drama - The Detroit News
Pfizer Reportedly Planning To Divest BioNTech Stake - BioSpace
New GIPR antagonists disclosed in Pfizer patent - BioWorld MedTech
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Rothschild & Co Redburn Adjusts Price Target on Pfizer to $24 From $25, Maintains Neutral Rating - MarketScreener
Pfizer Cuts BioNTech Stake by More Than Half - TradingView
Why analysts remain bullish on Pfizer Inc. stockTrade Analysis Report & Weekly Stock Performance Updates - Fundação Cultural do Pará
Will Pfizer Inc. stock test record highs in 2025July 2025 Pullbacks & Low Risk Entry Point Guides - Fundação Cultural do Pará
Lundbeck sparks bidding war with Alkermes; Pfizer closes Metsera deal - Yahoo Finance
Pfizer Stock Slips Premarket Despite Completing Metsera Deal; Investors React To BioNTech Stake Cut - Stocktwits
Pfizer Strengthens Pipeline With $10B Metsera Deal Amid Solid Q3 Results - Seeking Alpha
Pfizer completes Metsera acquisition in deal worth up to $10 bn - El Paso Inc.
Pfizer’s former R&D chief Dolsten pulls out of Novo Nordisk board race - 104.1 WIKY
Pfizer And Novo Nordisk Make Major Moves In Health Care - Finimize
Pfizer Buys Metsera To Jumpstart Its Obesity Drug Ambitions - Finimize
Pfizer's $10 Billion Obesity Drug Deal Could Reshape Treatment for 137 Million Americans - Stansberry Research
Pfizer slashes stake in COVID vaccine partner BioNTech - 104.1 WIKY
AK Health Dept. mails Pfizer-funded flyers telling Alaskans to vax to avoid illness, death - Alaska Watchman
Pfizer's former R&D chief Dolsten pulls out of Novo Nordisk board race - MarketScreener
Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race - Yahoo! Finance Canada
Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up By Reuters - Investing.com
Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up - Reuters
Pfizer Slashes Stake in COVID Vaccine Partner BioNTech - US News Money
Wachtell-Led Pfizer Closes Metsera Deal Worth Up To $10B - Law360
Pfizer Completes Acquisition of Metsera for $7 Billion - TipRanks
Pfizer completes $7 billion acquisition of Metsera with milestone payments - Investing.com
Pfizer completes $7 billion acquisition of Metsera with milestone payments By Investing.com - Investing.com South Africa
Pfizer completes acquisition of Metsera - MLex
Pfizer CEO says RFK Jr. wasn't his 'first choice' for HHS Secretary - Yahoo Finance
Pfizer CEO vows company will be a ‘formidable competitor’ in booming weight-loss market after $10B buy - MSN
Metsera holders vote to approve $10B sale to Pfizer, deal closes (update) (MTSR:NASDAQ) - Seeking Alpha
Is Pfizer Stock A Buy After It Clinches The $10 Billion Takeover Of Metsera? - Investor's Business Daily
Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up - Yahoo Finance
Metsera shareholders vote for up to $10 billion acquisition by Pfizer - 104.1 WIKY
CT’s Pfizer acquires obesity drug start-up. A ‘strategic milestone,’ pharmaceutical giant CEO said - Hartford Courant
Pfizer CEO Albert Bourla says aggressive bid for Metsera reflects company's 'right to win' obesity market - Yahoo Finance
Pfizer Stock (PFE) Rises as Metsera Shareholders Approve $10B Acquisition - TipRanks
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war? - TradingView
Pfizer CEO: AI will help with medicine's next big breakthrough - Yahoo Finance
Pfizer plans to enter GLP-1 space by 2028, CEO explains - Yahoo Finance
Pfizer Reports Completion Of Metsera Acquisition - MarketScreener
0.14%
0.22%
大文字化:
|
ボリューム (24 時間):